Women with ovarian cancer gain extra months with addition of drug to standard chemotherapy
The preliminary findings were reported here at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer. The phase III, randomized, controlled trial included women with platinum-sensitive recurrent ovarian cancer…